A Phase II Study of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone [CDD] for Relapsed or Refractory Multiple Myeloma
Title:
A Phase II Study of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone [CDD] for Relapsed or Refractory Multiple Myeloma
Author:
Fiala, Mark Keller, Jesse Sekhar, Jeevan Ceriotti, Connie Abboud, Camille DiPersio, John Tomasson, Michael Wildes, Tanya Stockerl-Goldstein, Keith Vij, Ravi